NewAmsterdam Pharma Co N.V 10-K for FY2024
NewAmsterdam Pharma Co N.V. (NAMS)
10-K
2025-02-26
For: 2024-12-31
View Original
Added on
April 09, 2026
About this 10-K
NewAmsterdam Pharma Co N.V filed this 10-K on February 26, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $45.56M
- up 223.4% from $14.09M a year earlier
- Net loss
- $241.6M
- compared with a net loss of $176.94M a year earlier
- Diluted EPS
- -$2.56
- compared with -$2.15 a year earlier